MONCTON — Moncton-based medical marijuana producer Organigram has a new Chief Financial Officer.
Paolo De Luca starts his new job Tuesday, the company announced. He replaces Peter Hanson, who has been interim CFO since March last year. Hanson will take over the role of Director of Finance.
CEO Greg Engel said in a release that De Luca is a “tremendous” addition to his team.
“His wide-ranging experience in both public and private capital markets, proven track record of successful financial stewardship and negotiations, and transformational vision will be an asset to the company as we transition from a strictly medical enterprise into a hybrid business including the adult recreational use market in 2018,” he said.
De Luca will lead the finance team that’s based in Moncton, as well as investor relations efforts. He will be based out of Organigram’s Toronto office.
A graduate of York University’s Schulich School of Business, De Luca has held senior financial, investor relations, and accounting leadership roles at companies including West Face Capital, Meridian LNG, Potash Ridge, C.A. Bancorp and TD Securities.
“With this diverse industry and international background, he has extensive experience with both traditional and non-traditional financing and debt offerings, which will be a tremendous asset to Organigram,” the company said in its press release.
“With a reputation for creative, high-energy leadership focused on the growth of dynamic companies, Mr. De Luca regularly draws upon his broad global experience and deep technical expertise to deliver unique and nontraditional financial solutions to complex issues supported by his sophisticated knowledge of capital markets, finance, technical accounting, tax and regulatory matters,” it said.
Organigram also moved Giselle Doiron, formerly Director of Investor and Media Relations, to a position in the Human Resources department. Investor Relations Analyst Dylan Rogers will manage investor relations inquiries.